Introduction. Under the conditions of circulatory disorders and coronary heart disease (CHD), amino acids acquire additional value as a source of intermediates of Krebs cycle, participating in cell energetics. If there is a disturbance of energy metabolism, the level of amino acids in the blood can change, including the minor non-encoding amino acid homoarginine (hArg).The objective of this study was to compare the shifts in the levels of hArg and other amino acids in the venous blood flowing from the tissues of the heart and brain versus their levels in blood plasma from the cubital vein in patients with CHD.Methods and materials. The study used plasma samples of 58 patients (46 men and 12 women) aged 62 (57 — 66) years with CHD and heart ...
Low plasma homoarginine (HA) is an emerging biomarker for cardiovascular disease and an independent ...
Aims Low levels of homoarginine and creatine are associated with heart failure severity in humans, b...
Background The endogenous amino acid homoarginine predicts mortality in cerebro‐ and cardiovascular ...
The goal of this study was to measure arterial amino acid levels in patients with chronic heart fail...
Aim of study – assessment of structure of the pool of free amino acids and related compounds in pati...
The goal of this study was to measure arterial amino acid levels in patients with chronic heart fail...
The heart has close interactions with other organs’ functions and concomitant systemic factors such ...
The heart has close interactions with other organs' functions and concomitant systemic factors such ...
The first description of homocysteine (Hcy), a non-proteinogenic amino acid, was introduced in a cas...
Clinical data indicate that low circulating l-homoarginine (HArg) concentrations are associated with...
Low homoarginine is an independent marker of mortality in heart failure patients and incident cardio...
Abstract High L-homoarginine (hArg) levels are directly associated with several risk factors for car...
Objective The objective of the study was to quantify the loss and arterial blood concentration of th...
L-Arginine:glycine amidinotransferase (AGAT) catalyzes the formation of L-homoarginine (hArg) and L-...
Cardiovascular disease is the leading global health concern and responsible for more deaths worldwid...
Low plasma homoarginine (HA) is an emerging biomarker for cardiovascular disease and an independent ...
Aims Low levels of homoarginine and creatine are associated with heart failure severity in humans, b...
Background The endogenous amino acid homoarginine predicts mortality in cerebro‐ and cardiovascular ...
The goal of this study was to measure arterial amino acid levels in patients with chronic heart fail...
Aim of study – assessment of structure of the pool of free amino acids and related compounds in pati...
The goal of this study was to measure arterial amino acid levels in patients with chronic heart fail...
The heart has close interactions with other organs’ functions and concomitant systemic factors such ...
The heart has close interactions with other organs' functions and concomitant systemic factors such ...
The first description of homocysteine (Hcy), a non-proteinogenic amino acid, was introduced in a cas...
Clinical data indicate that low circulating l-homoarginine (HArg) concentrations are associated with...
Low homoarginine is an independent marker of mortality in heart failure patients and incident cardio...
Abstract High L-homoarginine (hArg) levels are directly associated with several risk factors for car...
Objective The objective of the study was to quantify the loss and arterial blood concentration of th...
L-Arginine:glycine amidinotransferase (AGAT) catalyzes the formation of L-homoarginine (hArg) and L-...
Cardiovascular disease is the leading global health concern and responsible for more deaths worldwid...
Low plasma homoarginine (HA) is an emerging biomarker for cardiovascular disease and an independent ...
Aims Low levels of homoarginine and creatine are associated with heart failure severity in humans, b...
Background The endogenous amino acid homoarginine predicts mortality in cerebro‐ and cardiovascular ...